Zoloft PTSD Claim Clears FDA Cmte.; More Studies In Men Sought
Executive Summary
Additional trials of Pfizer's Zoloft (sertraline) in post-traumatic stress disorder should focus on the drug's treatment benefit in men, FDA's Psychopharmacologic Drugs Advisory Committee said Oct. 8. The committee recommended approval of the product for PTSD.
You may also be interested in...
Post Traumatic Stress Disorder Trials Should Use Fixed Dose, Committee Says
Sponsors seeking a post traumatic stress disorder indication should conduct fixed-dose studies, FDA's Psychopharmacologic Drugs Advisory Committee advised during its Oct. 8 review of Pfizer's Zoloft.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011